×
| Date | Author | Type | Reco Price | Target Price | Potential | Source | PDF Link |
|---|---|---|---|---|---|---|---|
| 03 Nov 2025 | Anand Rathi | Buy | ₹575.1 | ₹690 | 14.1% | moneycontrol | View |
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | 2.21 | -0.31 | NA | -1.25 | 0 | |
| INDRAPRASTHA MEDICAL CORP.LTD. | 3719.6 | 514.6 | 3650.6 | 5.61 | 4,096 | 24.4 |
| RPG LIFE SCIENCES LTD. | 1862.2 | 368.5 | 1816.8 | 0 | 3813 | 36.8 |
| Orchid Pharma Limited | 1888.59 | 181.97 | 1729.29 | 3.59 | 3659 | 42.9 |
Indraprastha Medical Corporation Lt, with Security Code 532150, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 274.1 | 306.5 | 317.0 | 306.5 | 314.7 | 347.9 | 349.8 | 324.9 | 333.8 | 365.1 |
| Expenses | 240.9 | 259.3 | 266.6 | 259.2 | 266.3 | 280.7 | 286.2 | 272.7 | 272.4 | 291.9 |
| Operating Profit | 33.1 | 47.3 | 50.4 | 47.3 | 48.4 | 67.1 | 63.6 | 52.2 | 61.4 | 73.2 |
| OPM % | 12.09% | 15.42% | 15.89% | 15.43% | 15.39% | 19.3% | 18.19% | 16.06% | 18.38% | 20.04% |
| Other Income | 4.8 | 3.6 | 4.2 | 4.3 | 4.9 | 5.1 | 6.1 | 5.1 | 6.4 | 6.9 |
| Interest | 0.9 | 0.8 | 0.9 | 0.9 | 1.6 | 1.6 | 1.6 | 1.6 | 1.5 | 1.6 |
| Depreciation | 9.9 | 9.8 | 10.0 | 10.0 | 10.2 | 11.0 | 11.2 | 11.2 | 10.9 | 10.2 |
| Profit before tax | 27.2 | 40.2 | 43.7 | 40.7 | 41.6 | 59.6 | 56.9 | 44.5 | 55.3 | 68.3 |
| Tax % | -27.1% | -24.2% | -24.7% | -27.6% | -25% | 24.9% | 25.5% | 26.3% | -25.7% | 24.7% |
| Net Profit | 19.8 | 30.5 | 32.9 | 29.4 | 31.2 | 44.8 | 42.4 | 32.8 | 41.0 | 51.5 |
| EPS in Rs | 2.16 | 3.33 | 3.58 | 3.21 | 3.4 | 4.88 | 4.63 | 3.58 | 0 | 5.61 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 10% |
| 3 Years: | 15% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 29% |
| 3 Years: | 37% |
| TTM: | 29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 62% |
| 3 Years: | 92% |
| 1 Year: | 68% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|